{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T09:07:08Z","timestamp":1768295228910,"version":"3.49.0"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.ejim.2022.03.017","type":"journal-article","created":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T01:32:45Z","timestamp":1647912765000},"page":"46-55","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["P2Y12 inhibitors plus aspirin for acute treatment and secondary prevention in minor stroke and high-risk transient ischemic attack: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"100","author":[{"given":"Fulvio","family":"Pomero","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6267-0526","authenticated-orcid":false,"given":"Eleonora","family":"Galli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Bellesini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenzo","family":"Maroni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5705-2897","authenticated-orcid":false,"given":"Alessandro","family":"Squizzato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2022.03.017_bib0001","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S1474-4422(19)30034-1","article-title":"Global, regional, and national burden of stroke, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"18","author":"Johnson","year":"2019","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ejim.2022.03.017_bib0002","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1212\/01.WNL.0000152985.32732.EE","article-title":"Timing of TIAs preceding stroke: time window for prevention is very short","volume":"64","author":"Rothwell","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.ejim.2022.03.017_bib0003","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1136\/bmj.37991.635266.44","article-title":"Population based study of early risk of stroke after transient ischaemic attack or minor stroke: implications for public education and organisation of services","volume":"328","author":"Coull","year":"2004","journal-title":"BMJ"},{"key":"10.1016\/j.ejim.2022.03.017_bib0004","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1056\/NEJMoa1412981","article-title":"One-year risk of stroke after transient ischemic attack or minor stroke","volume":"374","author":"Amarenco","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2022.03.017_bib0005","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/S0140-6736(97)04010-5","article-title":"CAST: randomised placebo-controlled trial of early aspirin use in 20 000 patients with acute ischaemic stroke","volume":"349","author":"Chen","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2022.03.017_bib0006","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0140-6736(97)04011-7","article-title":"The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. International Stroke Trial Collaborative Group","volume":"349","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2022.03.017_bib0007","doi-asserted-by":"crossref","first-page":"e344","DOI":"10.1161\/STROKEAHA.118.022606","volume":"50","author":"Powers William","year":"2019","journal-title":"Stroke"},{"key":"10.1016\/j.ejim.2022.03.017_bib0008","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0140-6736(16)30468-8","article-title":"Effects of aspirin on risk and severity of early recurrent stroke after transient ischaemic attack and ischaemic stroke: time-course analysis of randomised trials","volume":"388","author":"Rothwell","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2022.03.017_bib0009","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1056\/NEJMoa060989","article-title":"Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events","volume":"354","author":"Bhatt","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2022.03.017_bib0010","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S1474-4422(07)70250-8","article-title":"Fast assessment of stroke and transient ischaemic attack to prevent early recurrence (FASTER): a randomised controlled pilot trial","volume":"6","author":"Kennedy","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ejim.2022.03.017_bib0011","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1215340","article-title":"Clopidogrel with aspirin in acute minor stroke or transient ischemic attack","volume":"369","author":"Wang","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2022.03.017_bib0012","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1056\/NEJMoa1800410","article-title":"Clopidogrel and aspirin in acute ischemic stroke and high-risk TIA","volume":"379","author":"Johnston","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2022.03.017_bib0013","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1001\/jamaneurol.2019.2531","volume":"76","author":"Pan","year":"2019","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.ejim.2022.03.017_bib0014","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.k5108","article-title":"Clopidogrel plus aspirin versus aspirin alone for acute minor ischaemic stroke or high risk transient ischaemic attack: systematic review and meta-analysis","author":"Hao","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.ejim.2022.03.017_bib0015","doi-asserted-by":"crossref","DOI":"10.1177\/2396987321992905","article-title":"European Stroke Organisation (ESO) guidelines on management of transient ischaemic attack","author":"Fonseca","year":"2021","journal-title":"European Stroke Journal"},{"key":"10.1016\/j.ejim.2022.03.017_bib0016","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1056\/NEJMoa1916870","article-title":"Ticagrelor and aspirin or aspirin alone in acute ischemic stroke or TIA","volume":"383","author":"Johnston","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2022.03.017_bib0017","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005158.pub4","article-title":"Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular events","author":"Squizzato","year":"2017","journal-title":"Cochrane Database Systc Rev"},{"key":"10.1016\/j.ejim.2022.03.017_bib0018","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1136\/svn-2018-000168","article-title":"Dual versus mono antiplatelet therapy for acute non-cardioembolic ischaemic stroke or transient ischaemic attack: a systematic review and meta-analysis","volume":"3","author":"Yang","year":"2018","journal-title":"Stroke Vasc Neurol"},{"key":"10.1016\/j.ejim.2022.03.017_bib0019","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s11239-018-1786-z","article-title":"Clopidogrel and aspirin after ischemic stroke or transient ischemic attack: an updated systematic review and meta-analysis of randomized clinical trials","volume":"47","author":"Kheiri","year":"2019","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.ejim.2022.03.017_bib0020","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1056\/NEJM199309023291001","article-title":"An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction","volume":"329","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2022.03.017_bib0021","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","article-title":"Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients","volume":"3","author":"Schulman","year":"2005","journal-title":"J Thrombosis Haemostasis"},{"key":"10.1016\/j.ejim.2022.03.017_bib0022","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1161\/STROKEAHA.111.613273","article-title":"Simplified modified rankin scale questionnaire","volume":"42","author":"Askiel","year":"2011","journal-title":"Stroke"},{"key":"10.1016\/j.ejim.2022.03.017_bib0023","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.ejim.2022.03.017_bib0024","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1212\/WNL.0000000000001844","article-title":"Effect of clopidogrel with aspirin on functional outcome in TIA or minor stroke","volume":"85","author":"Wang","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.ejim.2022.03.017_bib0025","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1161\/CIRCULATIONAHA.119.040713","article-title":"Time course for benefit and risk of clopidogrel and aspirin after acute transient ischemic attack and minor ischemic stroke","volume":"140","author":"Claiborne","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2022.03.017_bib0026","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1161\/STROKEAHA.119.027465","article-title":"Disability after minor stroke and transient ischemic attack in the POINT trial","volume":"51","author":"Brett","year":"2020","journal-title":"Stroke"},{"key":"10.1016\/j.ejim.2022.03.017_bib0027","series-title":"Cochrane handbook for systematic reviews of interventions version 6.0 (updated July 2019)","article-title":"Chapter 10: analysing data and undertaking meta-analyses","author":"Deeks","year":"2019"},{"key":"10.1016\/j.ejim.2022.03.017_bib0028","series-title":"Cochrane handbook for systematic reviews of interventions version 6.0 (updated July 2019)","article-title":"Chapter 6: choosing effect measures and computing estimates of effect","author":"Higgins","year":"2019"},{"key":"10.1016\/j.ejim.2022.03.017_bib0029","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","article-title":"Grading quality of evidence and strength of recommendations","volume":"328","author":"Working Group","year":"2004","journal-title":"BMJ"},{"key":"10.1016\/j.ejim.2022.03.017_bib0030","series-title":"Cochrane handbook for systematic reviews of interventions version 6.0 (updated July 2019)","article-title":"Chapter 14: completing \u2018Summary of findings\u2019 tables and grading the certainty of the evidence","author":"Sch\u00fcnemann","year":"2019"},{"key":"10.1016\/j.ejim.2022.03.017_bib0031","unstructured":"McMaster University (2020) GRADEpro GDT: GRADEpro guideline development tool [Software]. https:\/\/gradepro.org. Accessed 2 Sep 2020."},{"key":"10.1016\/j.ejim.2022.03.017_bib0032","doi-asserted-by":"crossref","DOI":"10.1186\/s40169-019-0223-z","article-title":"Comparison of administration of clopidogrel with aspirin versus aspirin alone in prevention of secondary stroke after transient ischemic attack","author":"Khazaei","year":"2019","journal-title":"Clin Transl Med"},{"key":"10.1016\/j.ejim.2022.03.017_bib0033","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/S0140-6736(17)32849-0","article-title":"Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial","volume":"391","author":"Bath","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2022.03.017_bib0034","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S1474-4422(09)70361-8","article-title":"Early treatment with aspirin plus extended-release dipyridamole for transient ischaemic attack or ischaemic stroke within 24h of symptom onset (EARLY trial): a randomised, open-label, blinded-endpoint trial","volume":"9","author":"Dengler","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ejim.2022.03.017_bib0035","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/S0140-6736(06)68734-5","article-title":"Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial","volume":"367","author":"Halkes","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2022.03.017_bib0036","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-510X(96)00308-5","article-title":"European stroke prevention study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke","volume":"143","author":"Diener","year":"1996","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.ejim.2022.03.017_bib0037","article-title":"Treatment effect of clopidogrel plus aspirin within 12H of acute minor stroke or transient ischemic attack","author":"Li","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ejim.2022.03.017_bib0038","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1212\/WNL.0000000000001972","article-title":"Dual antiplatelet therapy in stroke and ICAS","volume":"85","author":"Liu","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.ejim.2022.03.017_bib0039","doi-asserted-by":"crossref","first-page":"12175","DOI":"10.18632\/aging.103394","article-title":"Combined impact of body mass index and glycemic control on the efficacy of clopidogrel-aspirin therapy in patients with minor stroke or transient ischemic attack","volume":"12","author":"Chen","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.ejim.2022.03.017_bib0040","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1111\/ene.14156","article-title":"Higher early recurrence risk and potential benefit of dual antiplatelet therapy for minor stroke with watershed infarction: subgroup analysis of CHANCE","volume":"27","author":"Pu","year":"2020","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.ejim.2022.03.017_bib0041","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1161\/ATVBAHA.119.313741","article-title":"Homocysteine level predicts response to dual antiplatelet in women with minor stroke or transient ischemic attack","volume":"40","author":"Jiejie","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ejim.2022.03.017_bib0042","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1001\/jamaneurol.2018.4775","article-title":"Association between ABCB1 polymorphisms and outcomes of clopidogrel treatment in patients with minor stroke or transient ischemic attack: secondary analysis of a randomized clinical trial","volume":"76","author":"Pan","year":"2019","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.ejim.2022.03.017_bib0043","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1111\/jch.13527","article-title":"The influence of mean arterial pressure on the efficacy and safety of dual antiplatelet therapy in minor stroke or transient ischemic attack patients","volume":"21","author":"Ma","year":"2019","journal-title":"J Clin Hypertension"},{"key":"10.1016\/j.ejim.2022.03.017_bib0044","doi-asserted-by":"crossref","DOI":"10.1111\/ene.13961","article-title":"Effect of dual versus mono antiplatelet therapy on recurrent stroke modulated by activated partial thromboplastin time","volume":"26","author":"Xie","year":"2019","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.ejim.2022.03.017_bib0045","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/s41397-018-0018-4","article-title":"Impact of CYP2C19 polymorphism in prognosis of minor stroke or TIA patients with declined eGFR on dual antiplatelet therapy: CHANCE substudy","volume":"18","author":"Wu","year":"2018","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.ejim.2022.03.017_bib0046","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.005446","article-title":"Recurrent stroke in minor ischemic stroke or transient ischemic attack with metabolic syndrome and\/or diabetes mellitus","author":"Chen","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ejim.2022.03.017_bib0047","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1001\/jamaneurol.2018.0247","article-title":"Dual antiplatelet therapy in transient ischemic attack and minor stroke with different infarction patterns: subgroup analysis of the CHANCE randomized clinical trial","volume":"75","author":"Jing","year":"2018","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.ejim.2022.03.017_bib0048","doi-asserted-by":"crossref","first-page":"861","DOI":"10.2147\/TCRM.S156694","article-title":"Effect of dual antiplatelet on recurrent stroke in minor stroke or TIA depends on bodyweight","volume":"14","author":"Ma","year":"2018","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.ejim.2022.03.017_bib0049","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1161\/STROKEAHA.117.019081","article-title":"Stress hyperglycemia and prognosis of minor ischemic stroke and transient ischemic attack","volume":"48","author":"Yuesong","year":"2017","journal-title":"Stroke"},{"key":"10.1016\/j.ejim.2022.03.017_bib0050","doi-asserted-by":"crossref","first-page":"3884","DOI":"10.1038\/s41598-017-04169-8","article-title":"Different levels of blood pressure, different benefit from dual antiplatelet therapy in minor stroke or TIA patients","volume":"7","author":"Xu","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.ejim.2022.03.017_bib0051","doi-asserted-by":"crossref","DOI":"10.5414\/CP202911","article-title":"Association between platelet function and recurrent ischemic vascular events after TIA and minor stroke","author":"Zhang","year":"2017","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.ejim.2022.03.017_bib0052","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1111\/cns.12329","article-title":"Recurrent stroke was associated with poor quality of life in patients with transient ischemic attack or minor stroke: finding from the CHANCE trial","volume":"20","author":"Wang","year":"2014","journal-title":"CNS Neurosci Ther"},{"key":"10.1016\/j.ejim.2022.03.017_bib0053","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.000912","article-title":"Cost-effectiveness of clopidogrel-aspirin versus aspirin alone for acute transient ischemic attack and minor stroke","volume":"3","author":"Pan","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ejim.2022.03.017_bib0054","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1161\/STROKEAHA.119.028713","article-title":"Efficacy of clopidogrel for prevention of stroke based on CYP2C19 allele status in the POINT trial","author":"Meschia","year":"2020","journal-title":"STROKE"},{"key":"10.1016\/j.ejim.2022.03.017_bib0055","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.10769","article-title":"Assessment of the end point adjudication process on the results of the platelet-oriented inhibition in new TIA and minor ischemic stroke (POINT) trial","author":"Farrant","year":"2019","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ejim.2022.03.017_bib0056","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1001\/jamaneurol.2019.0932","article-title":"Risk for major hemorrhages in patients receiving clopidogrel and aspirin compared with aspirin alone after transient ischemic attack or minor ischemic stroke: a secondary analysis of the POINT randomized clinical trial","volume":"76","author":"Tillman","year":"2019","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.ejim.2022.03.017_bib0057","article-title":"Risks and benefits of clopidogrel-aspirin in minor stroke or TIA: time course analysis of CHANCE","author":"Y","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.ejim.2022.03.017_bib0058","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1161\/CIRCULATIONAHA.114.014791","article-title":"Clopidogrel With Aspirin in Acute Minor Stroke or Transient Ischemic Attack (CHANCE) Trial: one-Year Outcomes","volume":"132","author":"Wang","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2022.03.017_bib0059","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1179\/1743132815Y.0000000087","article-title":"Combined clopidogrel\u2013aspirin treatment for high risk TIA or minor stroke does not increase cerebral microbleeds","volume":"37","author":"Wang","year":"2015","journal-title":"Neurol Res"},{"key":"10.1016\/j.ejim.2022.03.017_bib0060","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(13)60852-1","article-title":"Blood-pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial","volume":"382","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2022.03.017_bib0061","doi-asserted-by":"crossref","first-page":"e5497","DOI":"10.1097\/MD.0000000000005497","article-title":"The effectiveness and safety of dual antiplatelet therapy in ischemic cerebrovascular disease with intracranial and extracranial arteriostenosis in Chinese patients: a randomized and controlled trail","volume":"96","author":"Zuo","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ejim.2022.03.017_bib0062","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1093\/eurheartj\/ehi754","article-title":"Pharmacodynamics, pharmacokinetics, and safety of the oral reversible P2Y12 antagonist AZD6140 with aspirin in patients with atherosclerosis: a double-blind comparison to clopidogrel with aspirin","volume":"27","author":"Husted","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejim.2022.03.017_bib0063","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1001\/jama.2016.8662","article-title":"Association between CYP2C19 loss-of-function allele status and efficacy of clopidogrel for risk reduction among patients with minor stroke or transient ischemic attack","volume":"316","author":"Wang","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.ejim.2022.03.017_bib0064","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1161\/STROKEAHA.107.496281","article-title":"Aspirin plus dipyridamole versus aspirin for prevention of vascular events after stroke or TIA","volume":"39","author":"Piero","year":"2008","journal-title":"Stroke"},{"key":"10.1016\/j.ejim.2022.03.017_bib0065","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes","volume":"361","author":"Wallentin","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2022.03.017_bib0066","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1161\/01.STR.20.7.864","article-title":"Measurements of acute cerebral infarction: a clinical examination scale","volume":"20","author":"Brott","year":"1989","journal-title":"Stroke"},{"key":"10.1016\/j.ejim.2022.03.017_bib0067","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1212\/WNL.53.1.126","article-title":"Baseline NIH Stroke Scale score strongly predicts outcome after stroke: a report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST)","volume":"53","author":"Adams","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.ejim.2022.03.017_bib0068","first-page":"21","article-title":"Characteristics of the national institute of health stroke scale: results from a population-based stroke cohort at baseline and after one year","volume":"17","author":"Appelros","year":"2004","journal-title":"CED"},{"key":"10.1016\/j.ejim.2022.03.017_bib0069","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2016.00086","article-title":"Minor stroke and transient ischemic attack: research and practice","author":"Yakhkind","year":"2016","journal-title":"Front Neurol"},{"key":"10.1016\/j.ejim.2022.03.017_bib0070","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1161\/STROKEAHA.109.572883","article-title":"What is a minor stroke?","volume":"41","author":"Urs","year":"2010","journal-title":"Stroke"},{"key":"10.1016\/j.ejim.2022.03.017_bib0071","article-title":"Multiple versus fewer antiplatelet agents for preventing early recurrence after ischaemic stroke or transient ischaemic attack","volume":"8","author":"Naqvi","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ejim.2022.03.017_bib0072","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1161\/CIRCULATIONAHA.121.053782","article-title":"Efficacy and safety of using dual versus monotherapy antiplatelet agents in secondary stroke prevention: systematic review and meta-analysis of randomized controlled clinical trials","volume":"143","author":"Trifan","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2022.03.017_bib0073","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1001\/jamaneurol.2021.2440","article-title":"Efficacy and safety of ticagrelor and aspirin in patients with moderate ischemic stroke: an exploratory analysis of the THALES randomized clinical trial","volume":"78","author":"Wang","year":"2021","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.ejim.2022.03.017_bib0074","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1136\/svn-2020-000791","article-title":"Clopidogrel with aspirin in high-risk patients with acute non-disabling cerebrovascular events II (CHANCE-2): rationale and design of a multicentre randomised trial","volume":"6","author":"Wang","year":"2021","journal-title":"Stroke Vasc Neurol"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620522001066?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620522001066?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T09:38:12Z","timestamp":1760607492000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620522001066"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":74,"alternative-id":["S0953620522001066"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2022.03.017","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"P2Y12 inhibitors plus aspirin for acute treatment and secondary prevention in minor stroke and high-risk transient ischemic attack: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2022.03.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}